Interchange Capital Partners, LLC Actinium Pharmaceuticals, Inc. Transaction History

Interchange Capital Partners, LLC

  • $144 Million
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$8.51 - $14.26 $97,124 - $162,749
11,413 New
11,413 $107,000
Q4 2021

Feb 04, 2022
SELL
$6.01 - $8.8 $98,684 - $144,496
-16,420 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.76 - $9.67 $28,800 - $48,350
5,000 Added 43.78%
16,420 $145,000
Q2 2021

Aug 16, 2021
SELL
$7.01 - $8.63 $91,130 - $112,190
-13,000 Reduced 53.24%
11,420 $90,000
Q4 2020

Feb 16, 2021
BUY
$7.8 - $12.64 $190,476 - $308,668
24,420 New
24,420 $190,000

Others Institutions Holding ATNM

# of Institutions
72
Shares Held
6.65M
Call Options Held
369K
Put Options Held
148K
View Full List

About Actinium Pharmaceuticals, Inc.

ATNM Quotes by TradingView
  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $175M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email